Skip to main content

Table 2 PESI for PE risk and diagnosis

From: The prognostic value of pulmonary embolism severity index in acute pulmonary embolism: a meta-analysis

First author, Year PESI Risk Diagnosis
   All-cause death PE-related death Adverse outcome All-cause death PE-related death Adverse outcome
   PESI low risk PESI high risk PESI low risk PESI high risk PESI low risk PESI high risk Sensitivity Specific Sensitivity Specific Sensitivity Specific
Lankeit M, 2011 sPESI 1/198 (0.5%) 26/328 (7.9%) 0/198 (0.0%) 8/328 (2.4%) 2/198 (1.0%) 29/328 (8.8%) 0.963 0.395 1.000 0.382 0.935 0.396
Sánchez D, 2011 sPESI 7/407 (1.7%) 120/884 (13.6%) 2/407 (0.5%) 58/884 (6.6%) Not mentioned Not mentioned 0.945 0.344 0.967 0.329 N/A N/A
Lankeit M, 2012 sPESI 0/165 (0.0%) 40/361 (11.1%) Not mentioned Not mentioned 3/165 (1.8%) 18/361 (5.0%) 1.000 0.340 N/A N/A 0.857 0.321
Righini M, 2011 sPESI 1/165 (0.9%) 10/192 (5.2%) 1/165 (0.9%) 6/192 (3.0%) Not mentioned Not mentioned 0.909 0.474 0.857 0.469 N/A N/A
Spirk D, 2011 sPESI 0/106 (0.0%) 16/263 (6.1%) Not mentioned Not mentioned 3/106 (2.9%) 21/263 (8.0%) 1.000 0.394 N/A N/A 0.875 0.299
Vanni S, 2011 PESI 4/145 (2.8%) 34/318 (10.7%) 1/145 (0.7%) 24/318 (7.5%) 3/145 (2.1%) 29/318 (9.1%) 0.895 0.332 0.960 0.329 0.906 0.329
Venetz C, 2011 PESI 146/6332 (2.3%) 1234/9179 (14.1%) Not mentioned Not mentioned 63/6332 (1.0%) 275/9179 (3.0%) 0.894 0.438 N/A N/A 0.814 0.417
Venetz C, 2011 sPESI 134/5715 (2.7%) 1236/9816 (13.1%) Not mentioned Not mentioned 69/5715 (1.2%) 275/9816 (2.8%) 0.902 0.394 N/A N/A 0.799 0.372
Hariharan P, 2011 PESI Not mentioned Not mentioned Not mentioned Not mentioned 9/109 (8.3%) 54/136 (39.7%) N/A N/A N/A N/A 0.857 0.549
Jiménez D, 2011 PESI Not mentioned Not mentioned 1/199 (0.5%) 36/392 (9.2%) Not mentioned Not mentioned N/A N/A 0.973 0.357 N/A N/A
Singanayagam A, 2011 PESI 1/197 (0.5%) 22/214 (10.3%) Not mentioned Not mentioned Not mentioned Not mentioned 0.957 0.505 N/A N/A N/A N/A
Jiménez D, 2010 (Derivation Cohort) PESI 89/4235 (2.1%) 857/6119 (14.0%) Not mentioned Not mentioned Not mentioned Not mentioned 0.906 0.411 N/A N/A N/A N/A
Jiménez D, 2010 (Derivation Cohort) sPESI 3/305 (1.0%) 75/690 (10.9%) Not mentioned Not mentioned Not mentioned Not mentioned 0.962 0.329 N/A N/A N/A N/A
Jiménez D, 2010 (RIETE Cohort) sPESI 28/2565 (1.1%) 404/4541 (8.9%) Not mentioned Not mentioned Not mentioned Not mentioned 0.935 0.380 N/A N/A N/A N/A
Sam A, 2011 PESI 16/431 (3.7%) 103/775 (13.3%) Not mentioned Not mentioned Not mentioned Not mentioned 0.866 0.382 N/A N/A N/A N/A
Sam A, 2011 sPESI 6/369 (1.6%) 113/837 (13.5%) Not mentioned Not mentioned 8/369 (2.2%) 34/837 (4.1%) 0.950 0.334 N/A N/A 0.810 0.310
Chan CM, 2010 PESI 0/106 (0.0%) 9/196 (4.6%) Not mentioned Not mentioned Not mentioned Not mentioned 1.000 0.362 N/A N/A N/A N/A
Singanayagam A, 2010 PESI 6/288 (2.1%) 38/297 (12.8%) Not mentioned Not mentioned Not mentioned Not mentioned 0.864 0.521 N/A N/A N/A N/A
Moores L, 2010 PESI 2/191 (1.0%) 55/376 (14.6%) 1/191 (1.5%) 33/376 (8.8%) Not mentioned Not mentioned 0.965 0.371 0.971 0.356 N/A N/A
Nordenholz K, 2011 PESI 0/91 (0.0%) 5/77 (6.5%) Not mentioned Not mentioned Not mentioned Not mentioned 1.000 0.588 N/A N/A N/A N/A
Choi WH, 2009 PESI 3/39 (7.7%) 13/51 (25.5%) Not mentioned Not mentioned Not mentioned Not mentioned 0.813 0.486 N/A N/A N/A N/A
Donzé J, 2008 PESI 2/186 (1.1%) 19/171 (11.1%) Not mentioned Not mentioned Not mentioned Not mentioned 0.905 0.548 N/A N/A N/A N/A
Jiménez D, 2008 PESI 0/100 (0.0%) 12/218 (5.5%) Not mentioned Not mentioned Not mentioned Not mentioned 1.000 0.327 N/A N/A N/A N/A
Jiménez D, 2007 (Validation Cohort) PESI 2/216 (0.9%) 41/383 (10.7%) Not mentioned Not mentioned 6/216 (2.8%) 26/383 (6.8%) 0.953 0.385 N/A N/A 0.813 0.370
Aujesky D, 2007 PESI 5/426 (1.2%) 53/573 (9.2%) 3/426 (0.7%) 18/573 (3.1%) Not mentioned Not mentioned 0.914 0.447 0.857 0.433 N/A N/A
  1. Adverse outcome include nonfatal recurrent PE, nonfatal recurrent DVT, nonfatal bleeding, or delayed hemodynamic instability.